AstraZeneca pauses AZD1222 Covid-19 vaccine trials after unexpected illness

This article was originally published here

AZD1222, which is currently in phase 3 trials, has been seen as one of the most promising vaccine candidates across the world that is likely to be approved

The post AstraZeneca pauses AZD1222 Covid-19 vaccine trials after unexpected illness appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply